Here we report an unbiased analysis of the cytotoxic T lymphocyte (CTL) serine-threonine phosphoproteome by high-resolution mass spectrometry. We identified approximately 2,000 phosphorylations in CTLs, of which approximately 450 were controlled by T cell antigen receptor (TCR) signaling. A significantly overrepresented group of molecules identified included transcription activators, corepressors and chromatin regulators. A focus on chromatin regulators showed that CTLs had high expression of the histone deacetylase HDAC7 but continually phosphorylated and exported this transcriptional repressor from the nucleus. Dephosphorylation of HDAC7 resulted in its accumulation in the nucleus and suppressed expression of genes encoding key cytokines, cytokine receptors and adhesion molecules that determine CTL function. Screening of the CTL phosphoproteome has thus identified intrinsic pathways of serine-threonine phosphorylation that target chromatin regulators and determine the CTL functional program.
r e s o u r c e
Studies have shown that a network of signal-transduction pathways controlled by serine-threonine kinases such as mTOR, members of the AMP-activated kinase (AMPK) family and Akt (PKB) program cytotoxic T lymphocyte (CTL) fate [1] [2] [3] [4] [5] [6] [7] [8] . However, much of what is known about serine kinases in CTLs is based on experiments that confirm or refute the existence of evolutionarily conserved pathways of serine-threonine phosphorylation. For example, Akt-mediated phosphorylation of the transcription factors Foxo1 and Foxo3a results in their exclusion from the nucleus and the termination of Foxo-mediated gene transcription. This pathway of Foxo regulation is conserved in CTLs and has a key role in determining the repertoire of chemokine and adhesion receptors expressed by these cells 5,9 . A strategy that focuses on conserved serine kinases and their substrates in CTLs is valuable but limited in its potential in identifying previously unknown protein phosphorylations in these important cells. What is needed is an unbiased analysis of the full spectrum of protein phosphorylation in CTLs. In particular, defining the intrinsic network of basal protein phosphorylation in CTLs should identify the signaling pathways that maintain the essential epigenetic, transcriptional and metabolic programs that are permissive for CTL function. One way to achieve a global analysis of the cell phosphoproteome is through mass spectrometry. In particular, stable isotope labeling by amino acids in cell culture (SILAC) in combination with protocols for the enrichment of phosphorylated peptides (phosphopeptides) and high-resolution mass spectrometry represent powerful technologies with which to probe the cellular phosphoproteome 10 . The potential value of SILAC protocols is demonstrated by studies of T cell antigen receptor (TCR) signaling in the Jurkat T cell leukemic line [11] [12] [13] . The SILAC approach involves the incorporation of amino acids with substituted stable isotopic nuclei (in this case, 2 H, 13 C or 15 N) into cells. This strategy allows the analysis of various conditions in multiplex and bypasses many of the errors in reproducibility caused by the complex protocols used to purify phosphopeptides before mass spectrometry. Accordingly, our objective here was to use SILAC in combination with protocols for the enrichment of phosphorylated proteins (phosphoproteins) to explore the cytotoxic T cell phosphoproteome. Our experiments identified more than 2,000 phosphopeptides in CTLs, representative of more than 900 proteins either singly or multiply phosphorylated. Triggering of the TCR with complexes of cognate peptide and major histocompatibility complex modulated the phosphorylation of approximately 20% of the serine-threonine phosphoproteome of CTLs. The complex network of basal protein phosphorylation in CTLs before TCR engagement was notable and afforded insights about links between serine-threonine kinases and chromatin regulators that control the genes encoding important cytokines and cytokine receptors in CTLs. Collectively, our experiments demonstrate the power of unbiased phosphoproteomic analysis in delineating the molecular mechanisms that control CTL fate.
RESULTS
Analysis of the basal and TCR-regulated phosphoproteome in CTLs SILAC labeling requires that cells undergo multiple cell doublings in vitro. Accordingly, for SILAC experiments with CTLs, we used a r e s o u r c e well-characterized in vitro model of CTL differentiation based on the use of T cells from P14 TCR-transgenic mice 4, 14, 15 . P14 T cells in which the TCR is triggered that are cultured in interleukin 2 (IL-2) produce a homogenous population of effector CTLs 14, 15 . Moreover, this model reproduces the in vivo situation in which sustained IL-2 signaling promotes the production of terminally differentiated effector cytotoxic T cells [16] [17] [18] . For quantitative analysis of basal and TCR-regulated phosphorylation in CTLs, we labeled these cells with one of two different isotope combinations of lysine (K) and arginine (R): R0K0 and R10K8 (Supplementary Fig. 1 ). We then either left the CTLs unstimulated or triggered them with cognate peptide via their TCR. We then resolved trypsin-digested peptides from total cellular extracts by hydrophilic liquid-interaction chromatography (HILIC), followed by enrichment for phosphopeptides by immobilized metal ion-affinity chromatography (IMAC). We subsequently separated peptides by high-performance liquid chromatography (HPLC) coupled in line with a Linear Trap Quadrupole (LTQ)-Orbitrap XL for collection of mass spectrometry data. All raw mass spectrometry data were processed with MaxQuant software, which automatically does peptide-to-protein assignment and SILAC-based quantification of peptides and phosphorylation events, as well as phosphorylation-site localization in phosphopeptides identified.
The focus of our study here was serine and threonine phosphorylation. We identified 2,081 distinct serine-threonine phosphopeptides in CTLs derived from 955 proteins ( Fig. 1a ; full list, Supplementary  Table 1 ). We found that 22% of all quantified phosphorylation sites were regulated after TCR engagement. Triggering of the TCR with complexes of peptide and major histocompatibility complex thus led to changes in 450 phosphorylation sites, of which 391 were upregulated and 59 were downregulated ( Supplementary Table 1 ). Notably, these experiments captured previously described TCR-regulated phosphorylation of serine or threonine. For example, TCR triggering induced dephosphorylation of the transcription factor NFAT 19 and the actinremodeling protein cofilin 20 ( Table 1) . TCR triggering also resulted in more phosphorylation of the mitogen-activated protein kinases Erk1 and Erk2 and the microtubule-stabilizing protein stathmin on residues Ser25 and Ser16, which are known to be substrate sites for Erk1 and Erk2 and the TCR-regulated calcium-calmodulin dependent kinase IV 21 . Moreover, assessment with Ingenuity Pathway Analysis software independently concluded that the TCR-regulated phosphoproteins identified were components of TCR signal-transduction pathways ( Supplementary Fig. 2 ) and showed that a significantly overrepresented molecular function in all identified phosphoproteins was the control of gene transcription ( Fig. 1b) .
To determine the biological reproducibility of the results reported above ( Fig. 1) , we repeated the experiments four times, including switching of the amino acid labeling. Collective analysis of pooled data from multiple experiments confirmed that CTLs had high basal serine phosphorylation and that TCR triggering modified approximately 20% of these serine phosphorylations. We compiled a list of the basal and TCR-regulated serine-threonine phosphorylations identified in at least three of four experiments (full list, Supplementary  Table 2 ). We also used the Ingenuity Pathway Analysis software for canonical pathway analysis and analysis of molecular and cellular function pathways for the 742 consistent phosphorylations of 473 proteins identified in the CTLs (Fig. 2a ). This analysis indicated that the CTL phosphoproteome was significantly overrepresented by proteins that control RNA post-transcriptional modifications, protein synthesis, cell death, gene transcription and polymerization of actin (listing by group, Supplementary Fig. 3a,b ). TCR triggering consistently changed 94 phosphorylations of 81 proteins (including both upregulated and downregulated phosphorylations), which represented approximately 17% of all phosphorylated proteins found in our Figure 1 Analysis of the basal and TCRregulated phosphoproteome in CTLs. (a) SILAC ratio (TCR-stimulated/unstimulated) and signal intensity of phosphopeptides (n = 2,078) identified by mass spectrometry in lysates of P14 CTLs labeled with different isotopes (R10K8 (unstimulated) or R0K0 (stimulated)) in SILAC media and then left unstimulated (unstim) or triggered for 1 h via their TCR with cognate peptide (TCR stim), followed by cell lysis and purification of phosphopeptides by HILIC-IMAC enrichment (Supplementary Methods): black dots, phosphopeptides with phosphorylation downregulated or upregulated by TCR stimulation; gray dots, phosphopeptides not regulated by the TCR; in parentheses, selected proteins previously shown to change phosphorylation after TCR stimulation. A SILAC ratio of 1.5-fold serves as the threshold for regulation. Data are from a single experiment. (b) Molecular and cellular function of all 955 phosphoproteins identified (as assessed by Ingenuity Pathway Analysis): transcription (TC), developmental processes of lymphocytes (Dev), cell cycle (CC), lymphocyte homeostasis (LH) and phosphorylation (P). P values (vertical axis) indicate the probability that the function assigned is due to chance alone; numbers along the horizontal axis indicate total proteins in each group. Data are from a single experiment. r e s o u r c e screen ( Fig. 2b and Tables 2 and 3) . Notably, we identified previously unknown TCR-induced phosphorylations such as the phosphorylation of Cbx5 and TRIM28 ( Table 2 and Supplementary Tables 1 and 2), both proteins with chromatin-remodeling function. We used bioinformatics to identify the kinases most likely to phosphorylate the CTL phosphoproteins ( Fig. 2c and Table 4 ); this indicated activity of a minimum of at least 18 serine-threonine kinases in CTLs.
Phosphorylated chromatin regulators in CTLs
One challenge with any screen is how to choose targets for confirmation. However, in our experiments here, we initially focused on transcriptional regulators, as these were significantly overrepresented in the phosphoproteomic screens ( Fig. 2a) . The full list of this group ( Supplementary Fig. 3b ) included transcription factors, coactivators, DNA helicases and histone deacetylases (HDACs). We noted, however, that a subset of this list included molecules identified as regulators of chromatin ( Table 5 ). It is well known that the fate of any cell is determined by epigenetic regulation of gene loci. However, the molecular details of chromatin regulation in CTLs are poorly understood but are critical for understanding how CTLs maintain their effector status. We therefore considered all the chromatin regulators in CTLs found in the phosphoproteomic screens. We did not focus only on TCR-regulated phosphoproteins, such as Cbx5 and TRIM28, but also considered basally phosphorylated chromatin regulators, as these would be the molecules most likely to offer key insights about the control of CTL differentiation. In this context, there was consistent identification of the class I HDACs HDAC1 and HDAC2 and the class IIa HDAC HDAC7 as proteins constitutively phosphorylated in CTLs ( Table 5 ). These data were notable because selective control of histone acetylation underpins epigenetic regulation in all cells. In particular, histone acetylation destabilizes the nucleosome structure by neutralizing the positive charged lysine residues of the N-terminal tail domain of core histones 22 . Histone acetylation is regulated by the antagonistic activity of two groups of enzymes, histone acetyltransferases and HDACs, whereby HDACs promote chromatin condensation and transcriptional repression. The identification of HDAC1 and HDAC7 as proteins constitutively phosphorylated in CTLs was notable because phosphorylation of HDAC1 controls its enzymatic activity 23 , and phosphorylation of HDAC7 controls its intracellular localization and transcriptional repressor function [24] [25] [26] [27] [28] [29] [30] [31] . Moreover, there has been considerable analysis of the phosphorylation of HDAC7 during thymus development and in the DT40 B lymphoma cell line [25] [26] [27] 32 . The paradigm at present for HDAC7 regulation is that before triggering of the antigen receptor, nonphosphorylated HDAC7 localizes to the nucleus and represses gene transcription 33 . HDAC7 can function independently of its own intrinsic deacetylase activity and works by forming generepressive complexes on chromatin 34 . In contrast, phosphorylated HDAC7 is exported from the nucleus to the cytosol to dock with 14-3-3 adaptor proteins. The cytosolic retention of phosphorylated HDAC7 thus relieves the repressive actions of this class IIa HDAC on chromatin [25] [26] [27] [28] 35, 36 . It was not previously appreciated that HDAC7 is expressed in CTLs and it was particular notable that our screen identified HDAC7 as a CTL protein that was not regulated via the antigen receptor but instead was constitutively phosphorylated at Ser178, Ser204 and Thr342, phosphorylation sites known to control nuclear cytoplasmic shuttling of this molecule 25, 28, 36 . These data raise the possibility that HDAC7 controls the CTL transcriptional program. We therefore opted to design experimental strategies that would allow us to confirm the HDAC7-phosphorylation data and to probe the role of HDAC7 in CTLs.
Constitutive binding of 14-3-3 by HDAC7 in CTLs
The phosphorylations of HDAC7 identified in the HILIC-IMAC SILAC analyses of CTLs allowed us to predict that HDAC7 purified from CTLs would constitutively bind 14-3-3 proteins. To explore this possibility, we used 14-3-3 affinity purification and SILAC-mass spectrometry analysis to accurately identify and quantify HDAC7-14-3-3 associations 37 (Supplementary Methods). HDAC7 was consistently identified in the 14-3-3 complexes purified from control and TCR-triggered CTLs; there was no effect of TCR triggering on the binding of 14-3-3 by HDAC7 ( Table 6 ). We also did peptide manual sequencing of the acquired multistage activation spectra for the three HDAC7 peptides purified on the 14-3-3 complexes: KTVpS(178)EPNLK, KEpS(204)APPSLR and pT(342)RSEPLPPSA TASPLLAPLQPR (where pS and pT indicate phosphorylated serine or threonine, respectively, and numbers in parentheses indicate position of phosphorylated residue; Fig. 3a ). We used Biemann-Roepstorff nomenclature to label the acquired mass/charge (m/z) values of the peptide fragments of the corresponding precursor ion after Fig. 2) , presented as the SILAC ratio (as in Fig. 2b) , with phosphorylation sites and sequences; a SILAC ratio of 1.5-fold serves as the threshold for TCR regulation.
r e s o u r c e collision-induced dissociation; this terminology is based on the position on the peptide backbone of the fragmented bond and which fragment retains the charge: a charge carried on the C terminus is 'b' , a charge retained by the N terminus is 'y' , the amino acid position is subscripted, and loss of phosphate is indicated by an asterisk. This allowed us to identify the peptide sequence and supported the conclusion that HDAC7 Ser178 and Ser204 were correctly assigned phosphorylation sites. The data supporting the phosphorylation of HDAC7 Thr342 were more equivocal. The unmodified y 18 fragment ion of the peptide TRSEPLPPSATASPLLAPLQPR was identified ( Fig. 3a) , which indicated that the phosphorylated site was N-terminal of the glutamic acid residue at position 4 of the peptide. The b 4 * fragment ion with a loss of phosphate was also identified. However, there was no fragment ion signal closer to the N terminus than b 4 * and y 18 , which made phosphorylation of Ser344 and Thr342 equally likely. However, arginine-phosphorylated serine sequences are known to be resistant to cleavage by trypsin, which indicates that the actual site of phosphorylation would be Ser344 rather than Thr342. In this context, published studies have identified Ser344 rather than Thr342 as a phosphorylation site in HDAC7 (refs. 25, 28) .
Notably, we identified one other class IIa HDAC, HDAC4, in the 14-3-3 complexes purified from CTL lysates but did not find it consistently by the phosphopeptide-enrichment protocols. One explanation for this discrepancy is that the peptide enrichment on the 14-3-3 complexes allowed us to detect less-abundant proteins. Spectral counting, which quantifies the total tandem mass spectrometry spectra for peptides from a single protein, can be used quantify the relative abundance of proteins 38 . Thus, the probability that peptides derived from an abundant protein will lead to a tandem mass spectrometry event is higher than the probability that those derived from less-abundant proteins will do so. A spectral count accordingly provides a reliable quantitative assessment of protein abundance. Spectral analysis of the tandem mass spectrometry events for HDAC4 and HDAC7 from 14-3-3 affinity purifications showed that HDAC7 was at least ten times more abundant than HDAC4 in CTLs (Fig. 3b) . Collectively, the data show that HDAC7 was the predominant class II HDAC in CTLs and was constitutively phosphorylated on Ser178, Ser204 and Ser344 and constitutively docked with 14-3-3 complexes.
Constitutive localization of HDAC7 to CTL cytosol A distinctive feature of class IIa HDACs is their ability to shuttle between the nucleus and the cytosol. Nucleocytoplasmic shuttling is controlled by an N-terminal nuclear-localization sequence and a C-terminal leucine-rich nuclear-export signal (a putative recognition sequence for the CRM1 transporter) 30 . What was relevant to our data was that phosphorylation of HDAC7 on the N-terminal sites identified here directs the export of HDAC7 from the nucleus 24 . Phosphorylation of HDAC7 on the residues identified above ( Fig. 3) would therefore be predicted to cause HDAC7 to accumulate in the cytosol of CTLs. To probe the intracellular localization of endogenous HDAC7 in CTLs, we initially did immunoblot analysis of cytosolic and nuclear extracts of CTLs with antiserum to total HDAC7 (pan-HDAC7) and antiserum specific for phosphorylated HDAC that can cross-react with HDAC7 molecules phosphorylated on Ser178. Endogenous HDAC7 was constitutively phosphorylated on Ser178 and was in the cytosol of unstimulated CTLs and CTLs activated by stimulation of the TCR or with phorbol ester (Fig. 4a) . To further investigate the subcellular localization of HDAC7, we retrovirally transduced CTLs with a green fluorescent protein (GFP)-tagged fusion protein of HDAC7 (GFP-HDAC7). Immunoblot analysis indicated that GFP-HDAC7 was phosphorylated, localized to the cytosol in CTLs and was able to constitutively bind to 14-3-3 complexes (Fig. 4b) .
One question we considered was whether the pattern of HDAC7 localization in the P14 CTLs was universal. To address this issue, we examined the subcellular localization of HDAC7 in other T cell Sites in kinases predicted to be active that were consistently phosphorylated in CTLs (in at least three of four experiments) by MaxQuant software analysis (as in Fig. 2c ). Fig. 2 ), presented as in Table 2 .
r e s o u r c e populations. We found that HDAC7 was restricted to the cytosol of CTLs expressing a TCR recognizing the ovalbumin-derived peptide SIINFEKL (Fig. 4c) . CTLs produced by polyclonal activation also expressed HDAC7 in the cytosol (Fig. 4c) . Moreover, the cytosolic localization of HDAC7 was not restricted to activated T cells; HDAC7 also localized to the cytosol of naive CD4 + or CD8 + T cell populations (Fig. 4d) .
Notably, we confirmed the constitutive cytosolic location of GFP-HDAC7 by confocal imaging analysis of CTLs (Fig. 4e) . The export of phosphorylated class II HDACs from nucleus can be regulated by the CRM1 transporter 39 . We therefore considered whether the cytosolic localization of HDAC7 in T cells was static or whether it was dynamic and caused by the constant export of HDAC7 from the nucleus. To discriminate between these two possibilities, we treated GFP-HDAC7-expressing CTLs with leptomycin B, which efficiently blocks the transporter function of CRM1. Treatment of CTLs with leptomycin B caused time-dependent nuclear accumulation of HDAC7; within 3 h of leptomycin B treatment, the entire pool of HDAC7 recycled from the cytosol to the nucleus (Fig. 4f) . Hence, cytoplasmic retention of HDAC7 in CTLs is dynamic, not static, and is mediated by an active leptomycin B-sensitive nuclear export mechanism.
Role of the exclusion of HDAC7 from the nucleus of CTLs
How important to the biology of CTLs is the exclusion of HDAC7 from the nucleus? To explore this issue, we examined the effect of expressing a phosphorylation-deficient mutant of HDAC7 (GFP-HDAC7-∆P) in CTLs 25, 28, 35, 39 . This mutant has been used before to probe the HDAC7-regulated transcriptional program 36 . Confocal imaging analysis showed that GFP-HDAC7-∆P localized to the nucleus of CTLs (Fig. 5a,b) , in contrast to the distinct cytoplasmic localization of wild-type HDAC7 (Fig. 4e,f) . One initial insight of the effect of returning HDAC7 to the nucleus was provided by flow cytometry experiments probing the infection efficiency of the virus encoding GFP-HDAC7-∆P. CTLs are normally large proliferating cells, but analysis by flow cytometry of the FSC-H profile (a relative estimate of cell size) showed that CTLs expressing GFP-HDAC7-∆P were smaller (Fig. 5c ) than cells expressing wild-type GFP-HDAC7 or untransduced cells in the same culture. It also proved impossible to clonally expand CTLs transduced with the mutant HDAC7.
We therefore directly quantified the effect of expression of GFP-HDAC7-∆P on CTL proliferation. CTLs transduced with GFP-HDAC7-∆P survived but did not undergo normal IL-2-mediated proliferative expansion (Fig. 5d) . Hence, export of HDAC7 from the nucleus is needed to maintain CTL size and proliferative capacity.
To explore the molecular basis for the role of HDAC7 in CTLs, we used Affymetrix microarray analysis to assess the effect of GFP-HDAC7-∆P expression on the CTL transcriptional profile. Approximately 12,000 annotated genes were expressed in CTLs, and the effect of returning HDAC7 to the nucleus was lower expression of less than 2.5% of these and higher expression of another 6% (Fig. 5e) . The inhibitory effect of the HDAC7 mutant was thus very selective and limited to a small subset of the T cell transcriptome ( Fig. 5e and Supplementary Table 3 ). However, one notable observation was that GFP-HDAC7-∆P selectively repressed the expression of mRNA encoding CD25, a key subunit of the highaffinity receptor for IL-2 ( Table 7) . The selectivity of this effect of the GFP-HDAC7-∆P mutant on the T cell transcriptome was demonstrated by the finding that it downregulated expression of CD25 mRNA without affecting the expression of mRNA encoding other key cytokine receptors ( Table 7) . We confirmed the effect of GFP-HDAC7-∆P on the expression CD25 by quantitative PCR analysis (Fig. 6a) . Moreover, analysis of CD25 protein expression by flow cytometry of GFP-HDAC7-∆P-expressing CTLs and control cells (GFP − cells or cells expressing wild-type HDAC7) showed that expression of HDAC7-∆P resulted in lower expression of CD25 protein on CTLs (Fig. 6b,c) .
The strength and duration of IL-2 signaling is known to determine CTL differentiation and proliferation 16, 17 , and the ability of antigenprimed CTLs to respond to IL-2 is dependent on expression by these r e s o u r c e cells of a high-affinity receptor for IL-2 comprising CD25, CD122 and CD132 (the common γ-chain). In particular, CD25 expression is rate-limiting for the responsiveness of CTLs to IL-2 (refs. 16, 17) . The inability of CTLs expressing GFP-HDAC7-∆P to proliferate would thus be caused by the lower expression of CD25. Notably, CD25 expression was not completely obliterated by GFP-HDAC7-∆P. In particular, CTLs expressing the mutant HDAC7 had sufficient IL-2 signaling to survive. The cells thus had no higher expression of mRNA encoding proapoptopic molecules or loss of mRNA encoding survival molecules ( Table 8) .
High and prolonged expression of CD25 is needed to maintain CTL effector function 16, 17 . Accordingly, CTLs with low CD25 expression did not produce the effector cytokine interferon-γ (IFN-γ) in response to triggering of the antigen receptor (Fig. 6d,e) . Moreover, higher CD25 expression was accompanied by a greater ability to produce IFN-γ in response to triggering of the antigen receptor (Fig. 6d,e) . These data raised the possibility that that expression of HDAC7-∆P, which downregulated CD25 expression, might affect the antigen receptor-mediated responses of CTLs. We therefore examined the effect of nuclear localization of HDAC7 on the ability of CTLs to respond to antigen. CTLs that expressed GFP-HDAC7-∆P failed to produce IFN-γ when challenged by triggering of the TCR with cognate peptide (Fig. 6f) . Notably, this effect was cell autonomous, as the inhibitory effect of HDAC7-∆P was restricted to cells that expressed HDAC7-∆P and there was no 'cross-inhibition' of wild-type CTLs (that is, CTLs present in the cell culture that were not transduced by virus). These data show that although phosphorylation and nuclear exclusion of HDAC7 are not controlled by the TCR, they are involved in a regulatory process that can dictate the ability of T cells to mediate effector function in response to TCR triggering. 
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Anti-IκBα GFP-HDAC7 Figure 4 Subcellular distribution of HDAC7 in CTLs. (a) Immunoblot analysis of cytosolic (Cyt) and nuclear (Nuc) extracts of P14 CTLs left untreated (-) or treated for 30 min with peptide (TCR) or phorbol-12-13-dibutyrate (PD); antibody to IκBα (anti-IκBα) and anti-SCM1 serve as controls for fraction purity, and antibody to phosphorylated Erk (Anti-p-Erk1/2) serves as an activation control. Right margin, molecular size in kilodaltons (kDa). (b) Immunoprecipitation (IP) and immunoblot analysis of cytosolic and nuclear extracts of P14 CTLs left untransduced (-) or retrovirally transduced with GFP-HDAC7 (+), immunoprecipitated and probed with anti-GFP (top); cytosolic extracts of GFP-HDAC7-transduced CTLs left unstimulated (-) or stimulated for 2 h with phorbol-12-13-dibutyrate or peptide (as in a), immunoprecipitated with anti-GFP and probed with antibody to phosphorylated HDAC7 (middle); and cytosolic extracts of cells treated as in middle blot, followed by affinity purification with 14-3-3-sepharose (14-3-3 precip), probed with anti-GFP (bottom). (c) Immunoblot analysis of HDAC7 expression in cytosolic and nuclear extracts of CTLs from OT-I (ovalbumin-specific) TCR-transgenic mice and polyclonal, non-TCR-transgenic wild-type (WT) mice (n = two mice, WT1 and WT2). 
DISCUSSION
Here we have reported a high-resolution mass spectrometry analysis of a cytotoxic T cell serine-threonine phosphoproteome. Our results have identified a complex network of protein phosphorylation in CTLs before TCR engagement and have shown that TCR triggering perturbs this network, both increasing and decreasing phosphorylation of proteins with diverse functions in CTLs. One overrepresented group of phosphoproteins found in the phosphoproteomic screen was transcriptional regulators. This subset included chromatin regulators, notably HDAC1, HDAC2, HDAC4 and HDAC7. We focused on confirming the HDAC7 data and established that CTLs have high expression of this class IIa HDAC. Notably, there was a constitutive signaling pathway maintaining phosphorylation of HDAC7 in CTLs that was independent of TCR triggering. Phosphorylation of HDAC7 ensured constant induced export of this transcriptional repressor from the nucleus. This process was essential for sustaining high expression of CD25 in CTLs and hence was necessary for IL-2mediated cell growth and proliferation of CTLs. Export of HDAC7 from the nucleus was also needed for CTLs to respond to cognate antigen and produce the effector cytokine IFN-γ. Our results have thus shown that pathways of protein phosphorylation that are organized before TCR engagement can dictate the ability of T cells to mediate effector function in response to TCR triggering. In particular, basal non-TCR-regulated pathways of serine-threonine phosphorylation target a key HDAC in CTLs and control the expression of genes encoding cytokines, cytokine receptors and adhesion molecules that determine CTL function. The substantial basal phosphorylation and nuclear exclusion of HDAC7 in CTLs, in particular the absence of any TCR regulation of HDAC7 in CTLs, was different from what is known about HDAC7 regulation in the thymus. In such immature cells, phosphorylation and nuclear exclusion of HDAC7 is controlled by the TCR 25 . Phosphorylation of HDAC7 is mediated by the balanced activity of kinases and phosphatases. HDAC kinases include PKC-δ, PKD proteins, calcium-calmodulin-dependent kinases and the AMPK family kinase Mark2 (ref. 40 ). However, myosin phosphatase and protein phosphatase 2A have been characterized as HDAC7 phosphatases 41, 42 . The constitutive phosphorylation of HDAC7 in CTLs was thus an indication that CTLs have high basal activity of one or more of the HDAC kinases and low activity of its phosphatases. In this context, kinases of the AMPK family are active in CTLs and are important for CTL function, as indicated by the fact that deletion of LKB1, which phosphorylates and activates kinases of the AMPK family such as Mark2, causes CTLs to atrophy and die 43 . Other important insights about potential HDAC7 kinases in CTLs were provided by the use of bioinformatics to predict which kinases are active in CTLs. In this analysis, we used the known substrate specificities of serine-threonine kinases to identify the kinase most likely to phosphorylate the sites identified in the CTL mass spectrometry experiments. This modeling concluded that at least 18 different serine-threonine kinases were active in CTLs, including kinases of the AGC family, such as PKA or PKB. This conclusion was reassuring because it is known that PKB is active in CTLs and has a key role in controlling the effector function of these cells 5 . Similarly, the cytokine-induced kinases Pim-1 and Pim-2 were predicted to be active in CTLs, consistent r e s o u r c e with the known expression pattern of these kinases, which function to control the survival of T cells 44 . In the context of HDAC7, the modeling indicated that CTLs had high basal activity of calciumcalmodulin-dependent kinases and PKD, both of which can phosphorylate class II HDACs 45 . We focused on chromatin regulators here, but there were other insights about how protein phosphorylation might control T cell biology. For example, the realization that the main targets of serine-threonine kinases in T cells were proteins that control RNA stability, RNA cap methylation and protein synthesis was valuable because the ability of CTLs to maintain abundant protein synthesis is essential for the maintenance of CTL effector function. We also focused on a phosphorylation pathway in CTLs that was not regulated via the TCR. However, our data provided insights about how the TCR acts as an on-off switch to control CTL function. Hence, the main targets of TCR-regulated serine-threonine kinases are proteins that control the actin and microtubule cytoskeleton, such as cofilin and stathmin 20, 21 . Our data also showed that triggering of the TCR in CTLs caused rapid dephosphorylation of NFATc2, a process known to cause NFAT to translocate to the nucleus, where it controls expression of genes encopding cytokines 19 . In terms of additional perceptions, our data showed that CTLs expressed the transcription coregulator TRIM28 phosphorylated at Ser473. Moreover, TCR triggering reproducibly resulted in more phosphorylation of TRIM28 Ser473. TRIM28 controls gene expression and chromatin remodeling at specific loci by association with members of the heterochromatin protein 1 family and various other chromatin factors. In embryonic stem cells, phosphorylation of TRIM28 controls pluripotency 46 and, notably, phosphorylation of TRIM28 Ser473 has been shown to inhibit the binding of heterochromatin protein 1 and the corepressor function of TRIM28 (ref. 47) . The ability of the TCR to direct phosphorylation of TRIM28 Ser473 thus provides some additional ideas about how the TCR might control gene transcription in CTLs.
In summary, our study has identified many phosphorylations in CTLs and has shown how phosphoproteomic analysis can direct targeted hypothesis-driven experiments that provide information about the molecular mechanisms that control T cell function. It should be emphasized that although our experiments have identified several thousand previously unknown phosphopeptides in a CTL population, this is probably not complete coverage of the CTL phosphoproteome. Trypsin-digested phosphopeptides that were not stable or of the appropriate mass to be identified by mass spectrometry will have been missed. Moreover, mass spectrometry favors the identification of either abundant proteins or proteins phosphorylated at high stoichiometry. However, despite that proviso, our experiments have demonstrated the complexity of the T cell phosphoproteome and have shown how a basal network of protein phosphorylation maintains transcriptional programs that are permissive for T cell function. Our focus was on CTLs, but the ideas presented here are more generally applicable and indicative of the complexity of the phosphoproteome of all lymphocyte subpopulations. Indeed, a future challenge will be to compare the phosphoproteomes of different lymphocyte subsets to gain insight into the intrinsic and TCR-regulated signaling pathways that control T cell function. Gene expression (from microarray analysis) in CTLs expressing GFP-HDAC7-∆P, presented relative to expression in control (GFP − ) cells, for genes encoding products with known antiapoptotic or proapoptotic activity. Data are representative of a single experiment with triplicate samples.
r e s o u r c e METHODS Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
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